Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: J Shoulder Elbow Surg. 2022 Jun 4;31(11):2366–2380. doi: 10.1016/j.jse.2022.05.004

Figure 3: TPC delivery transiently increases neo-enthesis SOX9+ fibrocartilage cells.

Figure 3:

Representative images of Sox9 immunostaining for (A-C) fibrin-only and (D-F) TPC-treated mice. (G, H) Quantification shows increase in neo-enthesis Sox9+ cells at d7 but not d14 and d28 with TPC delivery. Dotted outline and solid rectangle indicate neo-enthesis and tendon-scar regions, respectively. Scale bars = 200 μm. * p≤0.05.